Hetero launches antiviral Covid-19 drug favipiravir at Rs 59 per tablet
Drug firm Hetero on Wednesday
said it has launched genericoral antiviral drug Favipiravir used forthe
treatment of patients with mild to moderate Covid-19,in India under the brand name 'Favivir' at Rs 59 per
tablet.
The company has been granted
the manufacturing and marketing approval for Favipiravir from the Drug Controller
General of India (DCGI), Hetero said in a statement.
Favivir is the second drug developed
by Hetero after Covifor (Remdesivir) used in the treatment of Covid-19, it
added.
Themedication has demonstrated
positive clinical outcomes. It improves treatment accessibility to a
significant amount of Covid-19 patient population, which have mild to moderate
symptoms, Hetero said. Read More
Comments
Post a Comment